A drug-delivery pump has to hold its seal for the entire labeled dosing period, whether that’s hours in an infusion pump or weeks in a wearable patch pump — there’s no maintenance window to catch a slow leak before it affects dosing accuracy. That reliability requirement starts with how the reservoir and pump housing are bonded.

Why Reservoir Sealing Is a High-Stakes Bonding Problem

Drug-delivery reservoirs and pump housings need to maintain a hermetic seal against both internal pressure from a driven infusion mechanism and external contamination, often for extended wear periods on ambulatory or wearable devices. A joint that passes an initial leak test but degrades slightly over the labeled use period can mean a dosing inaccuracy that’s difficult to detect until therapy is already affected — which makes long-term seal integrity, not just day-one bond strength, the real design target.

Many of these devices also combine rigid pump-body components with a flexible reservoir membrane or diaphragm, adding a mixed-substrate dimension to the sealing challenge on top of the pressure requirement itself.

Selecting the Right Incure Grade for Reservoir and Pump Bonding

The Incure Cyro-Weld™ 5002F is formulated specifically for hermetic bonding at reservoir-sealing and needle-hub joints, a 300–600 cP urethane acrylate that cures within seconds under 365–405 nm exposure and holds a service range of -55°C to 80°C — well matched to a reservoir seam or diaphragm-to-housing joint that has to hold pressure without gradual seepage over a multi-day wear period.

For pump-housing joints with wider or less consistent gaps, such as where an internal mechanism mounting bracket meets the outer shell, the Cyro-Weld™ 5017 (7,000–14,000 cP) gap-filling grade offers moisture and chemical resistance while bridging gaps that would starve a lower-viscosity hermetic sealant.

Where a rigid pump housing meets a flexible reservoir diaphragm, CTE mismatch causes adhesive bond failure is a common root cause of gradual seal degradation, particularly for devices worn against skin where body heat adds another thermal variable to the joint.

Sterilization and Biocompatibility Validation

Both grades are formulated to meet ISO 10993-5 cytotoxicity standards and are validated for Ethylene Oxide (ISO 11135) and Gamma (ISO 11137) sterilization pathways. As with all Incure materials, this reflects formulation-level validated data rather than a finished-device clearance — confirming seal integrity across your device’s full labeled wear duration, after your specific sterilization cycle, remains part of your own qualification process, since Incure supplies materials rather than cleared devices.

Given the dosing-accuracy implications of a marginal reservoir seal, it’s worth reviewing your specific pressure and wear-duration spec with our applications team before finalizing a bonding process — Email Us to start that conversation.

Common Failure Modes in Pump and Reservoir Assembly

Gradual seal seepage over a multi-day wear period is the most consequential failure mode for wearable drug-delivery devices, and it’s often not caught by a standard day-one leak test at all — it only shows up in extended wear-simulation testing, which is why reservoir-sealing joints should be validated against actual labeled wear duration rather than a shorter acceptance-test window. Diaphragm cracking at the bond line under repeated pump-actuation cycles is a second pattern, typically traced to a rigid adhesive used at a joint that experiences continuous mechanical flex from the driven mechanism rather than static pressure alone.

Incomplete cure from shadowing inside a pump housing’s internal geometry is a third recurring issue — internal ribs, bosses, and mounting features can block UV transmission to adhesive on the shielded side, even when an external inspection looks clean. Multi-angle exposure during cure, rather than a single fixed light position, addresses this more reliably than simply extending dose time.

FAQ

Q: How long should a reservoir seal be tested before releasing a device design?
A: Testing across the full labeled wear duration, under realistic pressure and temperature conditions, rather than a shorter standard acceptance window, gives a meaningfully better picture of long-term seal performance for wearable and ambulatory devices.

Q: Does adhesive choice affect dosing accuracy directly?
A: Indirectly but meaningfully — a reservoir seal that seeps even slightly over time can alter the effective delivered volume, so seal reliability over the full wear period is functionally part of the device’s dosing-accuracy performance, not a separate mechanical concern.

Q: Is a higher-viscosity adhesive always the safer choice for a reservoir seal?
A: Not automatically. A viscosity too high for a tight, consistent gap can leave voids rather than a continuous fillet, while one too low for a wider gap can flow away before cure completes — matching viscosity to the measured gap at each specific joint outperforms defaulting to the highest-viscosity option available.

Drug-delivery reservoir and pump bonding is ultimately a long-duration reliability problem, and grade selection should be validated against your device’s actual labeled wear period, not just an initial acceptance test. Our technical team can help — Contact Our Team for grade recommendations and sample material.

Visit www.incurelab.com for more information.